pyrazolanthrone has been researched along with dihydropyridines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, HQ; Li, Y; Wang, JG; Zou, J | 1 |
| Ito, S; Komatsubara, AT; Kyotani, Y; Nagayama, K; Ozawa, K; Tsuji, Y; Yoshizumi, M; Zhao, J | 1 |
2 other study(ies) available for pyrazolanthrone and dihydropyridines
| Article | Year |
|---|---|
Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells.
Topics: Amlodipine; Anthracenes; Butadienes; Calcium Channel Blockers; Cell Proliferation; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lipoproteins, LDL; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitriles; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Time Factors | 2012 |
Azelnidipine inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch.
Topics: Animals; Anthracenes; Antioxidants; Aorta; Azetidinecarboxylic Acid; Blood Pressure; Cells, Cultured; Dihydropyridines; Enzyme Inhibitors; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Onium Compounds; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley | 2014 |